rs768913997

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_000276.4(OCRL):​c.50G>C​(p.Gly17Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,207,170 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G17V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000012 ( 0 hom. 4 hem. )

Consequence

OCRL
NM_000276.4 missense

Scores

8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 4.18

Publications

1 publications found
Variant links:
Genes affected
OCRL (HGNC:8108): (OCRL inositol polyphosphate-5-phosphatase) This gene encodes an inositol polyphosphate 5-phosphatase. This protein is involved in regulating membrane trafficking and is located in numerous subcellular locations including the trans-Golgi network, clathrin-coated vesicles and, endosomes and the plasma membrane. This protein may also play a role in primary cilium formation. Mutations in this gene cause oculocerebrorenal syndrome of Lowe and also Dent disease. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
OCRL Gene-Disease associations (from GenCC):
  • Dent disease type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • oculocerebrorenal syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000276.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant X-129540754-G-C is Benign according to our data. Variant chrX-129540754-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436102.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000045 (5/110994) while in subpopulation AMR AF = 0.000284 (3/10576). AF 95% confidence interval is 0.0000768. There are 0 homozygotes in GnomAd4. There are 1 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 4 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000276.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCRL
NM_000276.4
MANE Select
c.50G>Cp.Gly17Ala
missense
Exon 2 of 24NP_000267.2
OCRL
NM_001318784.2
c.53G>Cp.Gly18Ala
missense
Exon 2 of 24NP_001305713.1
OCRL
NM_001587.4
c.50G>Cp.Gly17Ala
missense
Exon 2 of 23NP_001578.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCRL
ENST00000371113.9
TSL:1 MANE Select
c.50G>Cp.Gly17Ala
missense
Exon 2 of 24ENSP00000360154.4Q01968-1
OCRL
ENST00000357121.5
TSL:1
c.50G>Cp.Gly17Ala
missense
Exon 2 of 23ENSP00000349635.5Q01968-2
OCRL
ENST00000949289.1
c.50G>Cp.Gly17Ala
missense
Exon 2 of 24ENSP00000619348.1

Frequencies

GnomAD3 genomes
AF:
0.0000450
AC:
5
AN:
110994
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000284
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000379
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000273
AC:
5
AN:
183308
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000611
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000119
AC:
13
AN:
1096176
Hom.:
0
Cov.:
30
AF XY:
0.0000111
AC XY:
4
AN XY:
361604
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26364
American (AMR)
AF:
0.0000284
AC:
1
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19368
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30195
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54099
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40527
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4112
European-Non Finnish (NFE)
AF:
0.0000131
AC:
11
AN:
840268
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46039
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000450
AC:
5
AN:
110994
Hom.:
0
Cov.:
22
AF XY:
0.0000301
AC XY:
1
AN XY:
33194
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30556
American (AMR)
AF:
0.000284
AC:
3
AN:
10576
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2627
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3463
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2599
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6006
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.0000379
AC:
2
AN:
52766
Other (OTH)
AF:
0.00
AC:
0
AN:
1496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000567
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Lowe syndrome (1)
-
-
1
Nephrolithiasis/nephrocalcinosis (1)
-
-
1
not provided (1)
-
1
-
not specified (1)
-
1
-
OCRL-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.044
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
23
DANN
Benign
0.97
DEOGEN2
Benign
0.38
T
FATHMM_MKL
Benign
0.51
D
LIST_S2
Benign
0.82
T
M_CAP
Uncertain
0.17
D
MetaRNN
Uncertain
0.54
D
MetaSVM
Uncertain
0.34
D
MutationAssessor
Benign
2.0
M
PhyloP100
4.2
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-1.5
N
REVEL
Uncertain
0.46
Sift
Benign
0.076
T
Sift4G
Benign
0.31
T
PromoterAI
0.029
Neutral
Varity_R
0.21
gMVP
0.72
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs768913997;
hg19: chrX-128674731;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.